Skip to search.
 FTSE 100 Up 0.71%

Hyperion Therapeutics, Inc. (HPTX)

-NasdaqGS
45.96 Down 0.01(0.02%) 19:33 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:45.97
Open:45.97
Bid:45.94 x 200
Ask:45.95 x 800
1y Target Est:43.00
Beta:-0.14
Earnings Date:4 May - 8 May (Est.)
Day's Range:45.90 - 45.98
52wk Range:20.23 - 46.96
Volume:196,609
Avg Vol (3m):526,754
Market Cap:959.41m
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HPTXDown 0.02%959.41m
ALXNDown 2.92%34.90b
CPIXDown 2.73%114.95m
SLXP 0.00%N/A

Key Statistics

Forward P/E (1 yr):106.85
P/S (ttm):8.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :0.68
Quarterly EPS Est (Mar-15) :0.20
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hyperion Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat orphan diseases in the United states, Canada, and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback